We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Faith-Driven Serve Day Transforms Investor-Resident Relations
about 1 hour ago
LIG Assets Begins S-K 1300 Evaluation of Florida Calcium Mine
about 4 hours ago
Onco-Innovations Advances Precision Oncology with ONC010
about 5 hours ago
ReElement Technologies Secures Funding, Boosts Royalty Management
about 5 hours ago
DeFi Liquidity Wasted: 90% of Concentrated Funds Sit Idle
about 5 hours ago
Quantum Supercomputers Identify Fusion Fuel Breakthrough
about 5 hours ago
HR News
HR.com Unveils 2026 Employee Benefits Award Winners
1 day ago
Why Texas Startups Fail at Exit Prep: Fractional CFO Insights
1 day ago
isolved and Remote Unlock Global Hiring for SMBs
1 day ago
Recruiterie Partners with The Lutheran Collaborative to Strengthen Nonprofit Leadership
2 days ago
Frisco ISD Trustee Stephanie Elad on Growth, Trades, and Community Voice
7 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 2 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 2 months
Greenland Mines Adopts Stockholder Rights Plan to Block Coercive Takeovers
18 minutes ago
From Fix-and-Flip to Mega Builds: Private Lending Evolves
24 minutes ago
VERAXA Biotech Advances BiTAC®-TCE with Positive Regulatory Feedback
about 1 hour ago
Crypto News
DeFi Liquidity Wasted: 90% of Concentrated Funds Sit Idle
about 5 hours ago
Next Generation Trust Company Partners with ETZ Soft for Crypto IRA Trading
1 day ago
U.S. Freezes $130M+ in Iran-Linked Crypto Amid Middle East Tensions
2 days ago
Trump Urges Senate to Pass CLARITY Act in Memory of Lindsey Graham
6 days ago
Forward Industries Boosts SOL Treasury by 500K, Now Holds 7.55M SOL
6 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 2 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 2 months
VERAXA Biotech Advances BiTAC®-TCE with Positive Regulatory Feedback
about 1 hour ago
Onco-Innovations Advances Precision Oncology with ONC010
about 5 hours ago
Lantern Pharma Secures Key Patent for AI-Guided Cancer Therapy LP-184
about 6 hours ago
Technology News
Onco-Innovations Advances Precision Oncology with ONC010
about 5 hours ago
Royalty Management to Benefit from ReElement's $25M Defense Investment
about 5 hours ago
ReElement Technologies Secures Funding, Boosts Royalty Management
about 5 hours ago
Quantum Supercomputers Identify Fusion Fuel Breakthrough
about 5 hours ago
Samsung and Barclays Launch First US Credit Card
about 5 hours ago
Events & Conferences
SS Innovations to Showcase SSi Mantra Robotic System at SRS 2026
about 5 hours ago
Energy Fuels to Discuss Q2 2026 Results on Aug 6
about 6 hours ago
Avon Theatre Breaks Ground on Transformative Expansion and Renovation
about 12 hours ago
Faith Leaders Unite for Religious Freedom at Atlanta Prayer Night
about 12 hours ago
Landmark Worldwide Team Wins Royal Trophy at Bangkok Marathon for Red Cross
about 12 hours ago